Modelling the genetic risk in age-related macular degeneration.
about
Genetics and age-related macular degeneration: a practical review for the clinicianAMD Genetics in India: The Missing LinksThe Application of Genetic Risk Scores in Age-Related Macular Degeneration: A ReviewTapping Stem Cells to Target AMD: Challenges and ProspectsManagement of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in developmentContribution of microglia-mediated neuroinflammation to retinal degenerative diseasesA comparison of genomic profiles of complex diseases under different models.Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and ApoptosisEstimating the predictive ability of genetic risk models in simulated data based on published results from genome-wide association studies.Genetic-based prediction of disease traits: prediction is very difficult, especially about the futureA circulating microrna profile is associated with late-stage neovascular age-related macular degenerationGenome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degenerationCommon synonymous variants in ABCA4 are protective for chloroquine induced maculopathy (toxic maculopathy).A Candidate Gene Association Study Identifies DAPL1 as a Female-Specific Susceptibility Locus for Age-Related Macular Degeneration (AMD).Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degenerationDifferences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical SubtypesMultiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD).Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophyAge-related macular degeneration-clinical review and genetics update.Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs.The role of the complement system in age-related macular degeneration.Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium.Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits.The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration.Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration.A decade of age-related macular degeneration risk models: What have we learned from them and where are we going?Recombinant Haplotypes Narrow the ARMS2/HTRA1 Association Signal for Age-Related Macular Degeneration.Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes.An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure.Genetics and genetic testing for age-related macular degeneration.A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci.A mega-analysis of expression quantitative trait loci (eQTL) provides insight into the regulatory architecture of gene expression variation in liver.A systematic correlation of morphology and function using spectral domain optical coherence tomography and microperimetry in patients with geographic atrophy.Genetic risk factors and age-related macular degeneration (AMD).Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine
P2860
Q26738526-F93FEDCB-910B-4FC8-94FC-213D7FFAACBEQ26744092-ABF762F0-EA32-447F-B80D-6B93C6CABE7EQ26766721-33DB7590-FDA4-42DE-966F-627CBF8E06E9Q26799625-D01AA55C-EE70-4B59-B314-2A1B026E5B82Q26824335-2DF528E8-A7B2-41A6-B683-80374B0218C6Q27007111-FCAD2149-D8C0-471A-AFAB-A03875CD44B1Q27304707-2C02255F-CA41-4440-A919-452BF7374960Q28551885-CAEAA4F3-E1D5-4BBD-AC00-E3CC73E6895CQ30834328-1C26CFC7-DBD0-4786-8226-EE1F5FBE94C8Q33693846-B149475C-716F-4EFB-8685-01FCAF643E18Q34156202-C62264F5-C624-414A-83E7-48D68EF6D468Q34930448-CECDDD54-7021-4192-B464-F3739376CF4FQ35155368-5523A473-4A49-4233-9CE6-6748D5B13D3DQ35567948-90DFFB91-9EBF-48A7-B0C1-95CFF939C918Q35593465-B87BD66A-7FDD-4722-9D5A-BCB684FD57BFQ35870337-83851B11-E2EF-4E37-8CBA-6459CB6716B0Q36810588-8593B4D6-9BD9-4915-8309-EB59F542477CQ36961648-DAD3A374-98FC-4A4D-B595-96F1433B0067Q37068063-485F8CF1-D368-4DFF-B7F2-A1B4C60B4E01Q37610127-D2009D75-281D-44E2-BD5F-95227A9A7D25Q37646779-E7BF61E9-144C-4EB3-A214-ABF0DEC3594FQ37702757-5E8A20E2-666F-421A-8B66-FC48C92727FDQ37724216-D49D7ED2-B5BD-409B-BE2C-31651F7B4452Q38448712-D7429FD1-EA04-4880-B3DD-90A68D944E44Q38725575-3BC347CB-ADDB-4756-909E-7F155DAAD34DQ39024508-B04D0D7F-FECF-4BB2-8B84-0FD9CC5ABDECQ40460645-A61DC206-EC8E-49BF-BB9E-445FB58A390AQ41091252-92948F10-3B87-4F55-A49A-ACE2B3D4F602Q47123727-600E424C-343C-4C14-9765-34E5676B5D7FQ48326680-3703914D-DB01-4CFF-B32A-8056318BE8B8Q51324823-792F64D1-03F0-4C36-B950-5DC36A0CF36DQ52359171-6CE97589-B91B-4DA4-98CA-A2D1C5755B36Q52590951-129D9004-531F-455A-8BAD-910822AE0EC7Q53579704-AF5C5129-9C24-4821-8A1C-2E9AD72EBC75Q55551541-81176532-85D4-458F-8A17-0CD2EF1A3ABAQ58702202-BA3FB059-861A-4998-B100-DC36F89223A5
P2860
Modelling the genetic risk in age-related macular degeneration.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Modelling the genetic risk in age-related macular degeneration.
@ast
Modelling the genetic risk in age-related macular degeneration.
@en
Modelling the genetic risk in age-related macular degeneration.
@nl
type
label
Modelling the genetic risk in age-related macular degeneration.
@ast
Modelling the genetic risk in age-related macular degeneration.
@en
Modelling the genetic risk in age-related macular degeneration.
@nl
prefLabel
Modelling the genetic risk in age-related macular degeneration.
@ast
Modelling the genetic risk in age-related macular degeneration.
@en
Modelling the genetic risk in age-related macular degeneration.
@nl
P2860
P50
P1433
P1476
Modelling the genetic risk in age-related macular degeneration
@en
P2093
Claudia N Keilhauer
Iris M Heid
P2860
P304
P356
10.1371/JOURNAL.PONE.0037979
P407
P577
2012-05-30T00:00:00Z